• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗 2013 年 4 月至 2021 年 9 月全因超额死亡率和 COVID-19 报告病死率:按年龄和性别细分的时间序列分析。

Excess all-cause mortality and COVID-19 reported fatality in Iran (April 2013-September 2021): age and sex disaggregated time series analysis.

机构信息

National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Student's Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

BMC Res Notes. 2022 Apr 5;15(1):130. doi: 10.1186/s13104-022-06018-y.

DOI:10.1186/s13104-022-06018-y
PMID:35382865
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8981187/
Abstract

OBJECTIVE

The actual impact of the pandemic on COVID-19 specific mortality is still unclear due to the variability in access to diagnostic tools. This study aimed to estimate the excess all-cause mortality in Iran until September 2021 based on the national death statistics.

RESULTS

The autoregressive integrated moving average was used to predict seasonal all-cause death in Iran (R-squared = 0.45). We observed a 38.8% (95% confidence interval (CI) 29.7%-40.1%) rise in the all-cause mortality from 22 June 2020 to 21 June 2021. The excess all-cause mortality per 100,000 population were 178.86 (95% CI 137.2-220.5, M:F ratio = 1.3) with 49.1% of these excess deaths due to COVID-19. Comparison of spring 2019 and spring 2021 revealed that the highest percent increase in mortality was among men aged 65-69 years old (77%) and women aged 60-64 years old (86.8%). Moreover, the excess mortality among 31 provinces of Iran ranged from 109.7 (Hormozgan) to 273.2 (East-Azerbaijan) per 100,000 population. In conclusion, there was a significant rise in all-cause mortality during the pandemic. Since COVID-19 fatality explains about half of this rise, the increase in other causes of death and underestimation in reported data should be concerned by further studies.

摘要

目的

由于诊断工具获取的差异,大流行对 COVID-19 特异性死亡率的实际影响仍不清楚。本研究旨在根据国家死亡统计数据,估计截至 2021 年 9 月伊朗的全因超额死亡率。

结果

使用自回归综合移动平均法来预测伊朗全因季节性死亡(R 平方= 0.45)。我们观察到,自 2020 年 6 月 22 日至 2021 年 6 月 21 日,全因死亡率上升了 38.8%(95%置信区间(CI)29.7%-40.1%)。每 10 万人的全因超额死亡率为 178.86(95%CI 137.2-220.5,男女比例为 1.3),其中 49.1%的超额死亡归因于 COVID-19。将 2019 年春季和 2021 年春季进行比较,结果表明,死亡率增加最高的是年龄在 65-69 岁的男性(77%)和年龄在 60-64 岁的女性(86.8%)。此外,伊朗 31 个省份的超额死亡率范围为每 10 万人 109.7(霍尔木兹甘)至 273.2(东阿塞拜疆)。总之,大流行期间全因死亡率显著上升。由于 COVID-19 死亡率解释了这一上升的一半左右,因此其他死因的增加和报告数据的低估应该引起进一步研究的关注。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29fb/8981809/05cd9f9d8d26/13104_2022_6018_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29fb/8981809/4ec82de2f2c8/13104_2022_6018_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29fb/8981809/8056d1428d3f/13104_2022_6018_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29fb/8981809/05cd9f9d8d26/13104_2022_6018_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29fb/8981809/4ec82de2f2c8/13104_2022_6018_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29fb/8981809/8056d1428d3f/13104_2022_6018_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29fb/8981809/05cd9f9d8d26/13104_2022_6018_Fig3_HTML.jpg

相似文献

1
Excess all-cause mortality and COVID-19 reported fatality in Iran (April 2013-September 2021): age and sex disaggregated time series analysis.伊朗 2013 年 4 月至 2021 年 9 月全因超额死亡率和 COVID-19 报告病死率:按年龄和性别细分的时间序列分析。
BMC Res Notes. 2022 Apr 5;15(1):130. doi: 10.1186/s13104-022-06018-y.
2
The COVID-19 pandemic's true death toll in Iran after two years: an interrupted time series analysis of weekly all-cause mortality data.两年后伊朗 COVID-19 大流行的真实死亡人数:对每周全因死亡率数据的中断时间序列分析。
BMC Public Health. 2023 Mar 7;23(1):442. doi: 10.1186/s12889-023-15336-0.
3
Excess deaths associated with the Iranian COVID-19 epidemic: A province-level analysis.与伊朗新冠疫情相关的超额死亡:省级分析。
Int J Infect Dis. 2021 Jun;107:101-115. doi: 10.1016/j.ijid.2021.04.015. Epub 2021 Apr 13.
4
Excess Deaths During the COVID-19 Pandemic in Southern Iran: Estimating the Absolute Count and Relative Risk Using Ecological Data.伊朗南部 COVID-19 大流行期间的超额死亡人数:利用生态数据估计绝对数量和相对风险。
J Prev Med Public Health. 2024 Mar;57(2):120-127. doi: 10.3961/jpmph.23.198. Epub 2024 Feb 7.
5
Excess deaths during the COVID-19 pandemic in Iran.伊朗 COVID-19 大流行期间的超额死亡人数。
Infect Dis (Lond). 2022 Dec;54(12):909-917. doi: 10.1080/23744235.2022.2122554. Epub 2022 Sep 19.
6
Unexplained mortality during the US COVID-19 pandemic: retrospective analysis of death certificate data and critical assessment of excess death calculations.美国 COVID-19 大流行期间不明原因死亡率:死亡证明数据的回顾性分析和对超额死亡计算的批判性评估。
BMJ Open. 2021 Nov 16;11(11):e050361. doi: 10.1136/bmjopen-2021-050361.
7
Excess all-cause deaths stratified by sex and age in Peru: a time series analysis during the COVID-19 pandemic.秘鲁按性别和年龄分层的全因超额死亡人数:COVID-19 大流行期间的时间序列分析。
BMJ Open. 2022 Mar 10;12(3):e057056. doi: 10.1136/bmjopen-2021-057056.
8
Gender differences in estimated excess mortality during the COVID-19 pandemic in Thailand.泰国 COVID-19 大流行期间超额死亡率的性别差异。
BMC Public Health. 2023 Oct 2;23(1):1900. doi: 10.1186/s12889-023-16828-9.
9
Assessment of the Overall Mortality during the COVID-19 Outbreak in the Provinces of Milan and Lodi (Lombardy Region, Northern Italy).评估意大利北部伦巴第大区米兰省和洛迪省(Lodi)在 COVID-19 疫情爆发期间的总体死亡率。
Epidemiol Prev. 2020 Sep-Dec;44(5-6 Suppl 2):244-251. doi: 10.19191/EP20.5-6.S2.124.
10
Excess years of life lost to COVID-19 and other causes of death by sex, neighbourhood deprivation, and region in England and Wales during 2020: A registry-based study.2020 年英格兰和威尔士因 COVID-19 和其他死因导致的超额寿命损失及其与性别、社区贫困程度和地区的关系:一项基于登记的研究。
PLoS Med. 2022 Feb 15;19(2):e1003904. doi: 10.1371/journal.pmed.1003904. eCollection 2022 Feb.

引用本文的文献

1
All-Cause and Cause-Specific Excess Mortality During the First Two Years of the COVID-19 Pandemic in North-East of Iran: Reiterating the Significance of High-Quality Healthcare Systems.伊朗东北部新冠疫情大流行头两年的全因及特定病因超额死亡率:重申高质量医疗体系的重要性
Int J Health Policy Manag. 2025;14:8757. doi: 10.34172/ijhpm.8757. Epub 2025 May 21.
2
Assessing COVID-19 Mortality in Serbia's Capital: Model-Based Analysis of Excess Deaths.评估塞尔维亚首都的新冠疫情死亡率:基于模型的超额死亡分析
JMIR Public Health Surveill. 2025 Apr 17;11:e56877. doi: 10.2196/56877.
3
Excess mortality during the COVID-19 pandemic in low-and lower-middle-income countries: a systematic review and meta-analysis.

本文引用的文献

1
Decline and incomplete recovery in cancer diagnoses during the COVID-19 pandemic in Belgium: a year-long, population-level analysis.比利时 COVID-19 大流行期间癌症诊断的下降和不完全恢复:长达一年的人群水平分析。
ESMO Open. 2021 Aug;6(4):100197. doi: 10.1016/j.esmoop.2021.100197. Epub 2021 Jun 11.
2
Excess deaths reveal the true spatial, temporal and demographic impact of COVID-19 on mortality in Ecuador.超额死亡揭示了 COVID-19 对厄瓜多尔死亡率的真实空间、时间和人口统计学影响。
Int J Epidemiol. 2022 Feb 18;51(1):54-62. doi: 10.1093/ije/dyab163.
3
Quantifying and communicating the burden of COVID-19.
新冠大流行期间中低收入国家的超额死亡率:系统评价和荟萃分析。
BMC Public Health. 2024 Jun 20;24(1):1643. doi: 10.1186/s12889-024-19154-w.
4
COVID-19 vaccines breakthrough infection and adverse reactions in medical students: a nationwide survey in Iran.COVID-19 疫苗突破性感染与医学生不良反应:伊朗全国性调查
Front Public Health. 2024 Mar 13;12:1348015. doi: 10.3389/fpubh.2024.1348015. eCollection 2024.
5
Non-COVID-19 hospitalization and mortality during the COVID-19 pandemic in Iran: a longitudinal assessment of 41 million people in 2019-2022.伊朗2019-2022年新冠疫情期间非新冠病毒肺炎住院情况及死亡率:对4100万人的纵向评估
BMC Public Health. 2024 Feb 5;24(1):380. doi: 10.1186/s12889-024-17819-0.
6
Gender differences in estimated excess mortality during the COVID-19 pandemic in Thailand.泰国 COVID-19 大流行期间超额死亡率的性别差异。
BMC Public Health. 2023 Oct 2;23(1):1900. doi: 10.1186/s12889-023-16828-9.
7
Global Excess Mortality during COVID-19 Pandemic: A Systematic Review and Meta-Analysis.新冠疫情期间的全球超额死亡率:一项系统评价与荟萃分析
Vaccines (Basel). 2022 Oct 12;10(10):1702. doi: 10.3390/vaccines10101702.
量化和传播 COVID-19 的负担。
BMC Med Res Methodol. 2021 Aug 10;21(1):164. doi: 10.1186/s12874-021-01349-z.
4
Excess Deaths During the COVID-19 Pandemic: Implications for US Death Investigation Systems.新冠疫情期间的超额死亡:对美国死亡调查系统的影响
Am J Public Health. 2021 Jul;111(S2):S53-S54. doi: 10.2105/AJPH.2021.306331.
5
Exploring the Gap Between Excess Mortality and COVID-19 Deaths in 67 Countries.探索 67 个国家超额死亡率与 COVID-19 死亡人数之间的差距。
JAMA Netw Open. 2021 Jul 1;4(7):e2117359. doi: 10.1001/jamanetworkopen.2021.17359.
6
Out-of-hospital cardiac arrests and mortality in Swiss Cantons with high and low COVID-19 incidence: A nationwide analysis.瑞士新冠病毒病发病率高和低的州的院外心脏骤停与死亡率:一项全国性分析。
Resusc Plus. 2021 Mar 2;6:100105. doi: 10.1016/j.resplu.2021.100105. eCollection 2021 Jun.
7
Tracking excess mortality across countries during the COVID-19 pandemic with the World Mortality Dataset.利用世界死亡率数据集追踪 COVID-19 大流行期间各国的超额死亡率。
Elife. 2021 Jun 30;10:e69336. doi: 10.7554/eLife.69336.
8
Disease-Specific Excess Mortality During the COVID-19 Pandemic: An Analysis of Weekly US Death Data for 2020.2020 年美国每周死亡数据分析:新冠大流行期间特定疾病超额死亡率。
Am J Public Health. 2021 Aug;111(8):1518-1522. doi: 10.2105/AJPH.2021.306315. Epub 2021 Jun 29.
9
Excess deaths associated with covid-19 pandemic in 2020: age and sex disaggregated time series analysis in 29 high income countries.2020 年与新冠大流行相关的超额死亡人数:29 个高收入国家按年龄和性别细分的时间序列分析。
BMJ. 2021 May 19;373:n1137. doi: 10.1136/bmj.n1137.
10
Characterizing all-cause excess mortality patterns during COVID-19 pandemic in Mexico.描述墨西哥 COVID-19 大流行期间全因超额死亡率的模式。
BMC Infect Dis. 2021 May 7;21(1):432. doi: 10.1186/s12879-021-06122-7.